Clinical trial
Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
NCT00119431 · Prothya Biosolutions, Industry · Completed
Key facts
| NCT number | NCT00119431 |
|---|---|
| Title | Kinetics, Efficacy and Safety of C1-Esteraseremmer-N |
| Official title | Pharmacokinetics, Clinical Efficacy and Safety of C1 Inhibitor Concentrate (C1-Esteraseremmer-N) for the Treatment of Hereditary (and Acquired) Angioedema |
| Lead sponsor | Prothya Biosolutions, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hereditary Angioedema Type I, Angioneurotic Edema |
| Intervention type | Drug |
| Interventions | C1 inhibitor concentrate |
| Enrollment | 12 |
| Start date | Sep 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Jul 13, 2005 |
| Last update posted | May 4, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: